These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 19515219)

  • 1. Expanding the severity range of polytetrafluoroethylene-related hepatic outflow occlusion.
    Airoldi A; Vangeli M; Vizzutti F; Pinzani M; Minola E; Rampoldi A; Pinzello G
    Liver Int; 2009 Sep; 29(8):1288-9. PubMed ID: 19515219
    [No Abstract]   [Full Text] [Related]  

  • 2. Liver failure complicating segmental hepatic ischaemia induced by a PTFE-coated TIPS stent.
    Vizzutti F; Arena U; Rega L; Zipoli M; Abraldes JG; Romanelli RG; Tarquini R; Laffi G; Pinzani M
    Gut; 2009 Apr; 58(4):582-4. PubMed ID: 19299387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of Budd-Chiari syndrome in a liver transplant unit, the role of transjugular intrahepatic porto-systemic shunt and liver transplantation.
    Attwell A; Ludkowski M; Nash R; Kugelmas M
    Aliment Pharmacol Ther; 2004 Oct; 20(8):867-73. PubMed ID: 15479358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transjugular intrahepatic portosystemic shunt in the management of Budd Chiari syndrome.
    Olliff SP
    Eur J Gastroenterol Hepatol; 2006 Nov; 18(11):1151-4. PubMed ID: 17033433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Transjugular intrahepatic portosystemic shunt in the treatment of Budd-Chiari syndrome with extensive occlusion of the hepatic veins].
    Wu XJ; Cao JM; Han JM; Li JS
    Zhonghua Wai Ke Za Zhi; 2006 Aug; 44(15):1029-32. PubMed ID: 17074238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of Budd-Chiari syndrome by transjugular intrahepatic portosystemic shunt.
    Panagiotou I; Kelekis DA; Karatza C; Nikolaou V; Mouyia V; Brountzos EN
    Hepatogastroenterology; 2007 Sep; 54(78):1813-6. PubMed ID: 18019724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Diagnosis, treatment and evolution of the Budd-Chiari syndrome: a single center experience].
    Solari J; Bandi JC; Galdame O; Marciano S; Mullen E; Garcia MR; Nucifora E; de Santibañes E; Gadano A
    Acta Gastroenterol Latinoam; 2010 Sep; 40(3):225-35. PubMed ID: 21053481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term outcome of a covered vs. uncovered transjugular intrahepatic portosystemic shunt in Budd-Chiari syndrome.
    Darwish Murad S; Luong TK; Pattynama PM; Hansen BE; van Buuren HR; Janssen HL
    Liver Int; 2008 Feb; 28(2):249-56. PubMed ID: 18251982
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Late intrahepatic hematoma complicating transjugular intrahepatic portosystemic shunt for Budd-Chiari syndrome.
    Terreni N; Vangeli M; Raimondo ML; Tibballs JM; Patch D; Burroughs AK
    Cardiovasc Intervent Radiol; 2007; 30(2):335-8. PubMed ID: 17206393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transjugular intrahepatic portosystemic shunt for portal vein thrombosis with and without underlying cirrhosis.
    Senzolo M; Patch D; Cholongitas E; Burroughs AK
    Cardiovasc Intervent Radiol; 2007; 30(3):545; author reply 546. PubMed ID: 17242876
    [No Abstract]   [Full Text] [Related]  

  • 11. Liver transplantation for Budd-Chiari syndrome: when is it really necessary?
    Darwish Murad S; Kamath PS
    Liver Transpl; 2008 Feb; 14(2):133-5. PubMed ID: 18236445
    [No Abstract]   [Full Text] [Related]  

  • 12. Incarcerated umbilical hernia after transjugular intrahepatic portosystemic shunt procedure for refractory ascites.
    Mallavarapu RK; Grimsley EW
    Clin Gastroenterol Hepatol; 2007 Sep; 5(9):A26. PubMed ID: 17825762
    [No Abstract]   [Full Text] [Related]  

  • 13. Prevention of transjugular intrahepatic portosystemic stent shunt thrombosis.
    Sauer P; Theilmann L
    Digestion; 1998 Jul; 59 Suppl 2():45-7. PubMed ID: 9718419
    [No Abstract]   [Full Text] [Related]  

  • 14. Budd-Chiari syndrome and essential thrombocythemia in a child: favorable outcome after transjugular intrahepatic portosystemic shunt.
    Hermeziu B; Franchi-Abella S; Plessier A; Habes D; Mosca A; Sibert A; Bernard O; Pariente D; Jacquemin E
    J Pediatr Gastroenterol Nutr; 2008 Mar; 46(3):334-7. PubMed ID: 18376254
    [No Abstract]   [Full Text] [Related]  

  • 15. Comments to: Budd-Chiari syndrome: current options in the interventional radiology treatment exemplified by three selected cases.
    Guan Y
    Med Sci Monit; 2006 Oct; 12(10):LE19-20. PubMed ID: 17006410
    [No Abstract]   [Full Text] [Related]  

  • 16. Long-term effect of treatment of acute Budd-Chiari syndrome with a transjugular intrahepatic portosytemic shunt.
    Blokzijl H; de Knegt RJ
    Hepatology; 2002 Jun; 35(6):1551-2. PubMed ID: 12029648
    [No Abstract]   [Full Text] [Related]  

  • 17. Use of the Arrow percutaneous thrombectomy device and transjugular liver biopsy cannula for mechanical thrombectomy of the inferior vena cava in a patient with Budd-Chiari syndrome.
    Haskal ZJ
    J Vasc Interv Radiol; 2007 Jul; 18(7):924-7. PubMed ID: 17609456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transjugular Intrahepatic Portosystemic Shunt (TIPS), the preferred therapeutic option for Budd Chiari syndrome associated with portal vein thrombosis.
    Senzolo M; Cholongitas E; Davies N; Marelli L; Shusang V; Patch D; Burroughs AK
    Am J Gastroenterol; 2006 Sep; 101(9):2163-4; author reply 2164-5. PubMed ID: 16968512
    [No Abstract]   [Full Text] [Related]  

  • 19. Anesthetic management of combined heart-liver transplantation.
    Diaz GC; Renz JF; Nishanian E; Kinkhabwala M; Emond JC; Wagener G
    J Cardiothorac Vasc Anesth; 2007 Apr; 21(2):253-6. PubMed ID: 17418742
    [No Abstract]   [Full Text] [Related]  

  • 20. [Formation of a pseudoaneurysm in the liver after TIPSS implantation in Budd-Chiari syndrome].
    Wilhelmsen S; Rickes S; Ricke J
    Rofo; 2008 Feb; 180(2):155-7. PubMed ID: 18058637
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.